Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gou-Teng-San (GTS), also known as Choto-san in Kampo medicine, is a traditional East Asian herbal formula primarily used for the treatment of headaches, hypertension, and dizziness. The formula is composed of multiple herbs, with *Uncaria rhynchophylla* (Gou Teng) serving as the principal component. GTS contains various bioactive indole alkaloids, such as rhynchophylline and hirsutine, which are thought to exert neuroprotective, anti-inflammatory, and vasodilatory effects. These actions are likely mediated through the modulation of neurotransmitter systems (including serotonin) and the blockade of voltage-gated calcium channels. In clinical research led by Dr. Chueh-Yi Tsai, GTS is being evaluated in a Phase 3 trial as a prophylactic treatment for episodic migraine to reduce attack frequency and improve patient quality of life.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gou-Teng-San.